ImmuneXcite Garners $8,600,000 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3f496685-d9ba-4584-927d-4519115b0559
Date
12/11/2015
Company Name
ImmuneXcite
Mailing Address
3 Forbes Road Lexington, MA 02421 USA
Company Description
ImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.
Website
http://www.immunexcite.com
Transaction Type
Venture Equity
Transaction Amount
$8,600,000
Transaction Round
Series A
Proceeds Purposes
ImmuneXcite plans to use the funding to complete studies that will enable selection of a lead program to advance into clinical trials.
M&A Terms
Venture Investor
Cormorant Asset Management
Venture Investor
Sanofi-Genzyme BioVentures
Venture Investor
Partners Innovation Fund